Sanacora G - Search Results

1

Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Haroon E, Miller AH, Sanacora G. Haroon E, et al. Among authors: sanacora g. Neuropsychopharmacology. 2017 Jan;42(1):193-215. doi: 10.1038/npp.2016.199. Epub 2016 Sep 15. Neuropsychopharmacology. 2017. PMID: 27629368 Free PMC article. Review.

2

Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.

Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, Epperson CN, Goddard A, Mason GF. Krystal JH, et al. Among authors: sanacora g. Mol Psychiatry. 2002;7 Suppl 1:S71-80. doi: 10.1038/sj.mp.4001021. Mol Psychiatry. 2002. PMID: 11986998 Review.

3

Clinical studies implementing glutamate neurotransmission in mood disorders.

Sanacora G, Rothman DL, Mason G, Krystal JH. Sanacora G, et al. Ann N Y Acad Sci. 2003 Nov;1003:292-308. doi: 10.1196/annals.1300.018. Ann N Y Acad Sci. 2003. PMID: 14684453 Review.

4

Beyond monoamines: glutamatergic function in mood disorders.

Kugaya A, Sanacora G. Kugaya A, et al. Among authors: sanacora g. CNS Spectr. 2005 Oct;10(10):808-19. doi: 10.1017/s1092852900010403. CNS Spectr. 2005. PMID: 16400244 Review.

5

Targeting glial physiology and glutamate cycling in the treatment of depression.

Valentine GW, Sanacora G. Valentine GW, et al. Among authors: sanacora g. Biochem Pharmacol. 2009 Sep 1;78(5):431-9. doi: 10.1016/j.bcp.2009.04.008. Epub 2009 Apr 17. Biochem Pharmacol. 2009. PMID: 19376090 Free PMC article.

6

Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

Sanacora G, Treccani G, Popoli M. Sanacora G, et al. Neuropharmacology. 2012 Jan;62(1):63-77. doi: 10.1016/j.neuropharm.2011.07.036. Epub 2011 Aug 3. Neuropharmacology. 2012. PMID: 21827775 Free PMC article. Review.

7

Overview of glutamatergic neurotransmission in the nervous system.

Niciu MJ, Kelmendi B, Sanacora G. Niciu MJ, et al. Among authors: sanacora g. Pharmacol Biochem Behav. 2012 Feb;100(4):656-64. doi: 10.1016/j.pbb.2011.08.008. Epub 2011 Aug 26. Pharmacol Biochem Behav. 2012. PMID: 21889952 Free PMC article. Review.

8

From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders.

Sanacora G, Banasr M. Sanacora G, et al. Biol Psychiatry. 2013 Jun 15;73(12):1172-9. doi: 10.1016/j.biopsych.2013.03.032. Biol Psychiatry. 2013. PMID: 23726152 Free PMC article. Review.

9

Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

Sanacora G, Schatzberg AF. Sanacora G, et al. Neuropsychopharmacology. 2015 Jan;40(2):259-67. doi: 10.1038/npp.2014.261. Epub 2014 Sep 26. Neuropsychopharmacology. 2015. PMID: 25257213 Free PMC article. Review.

10

Regulation of extrasynaptic glutamate levels as a pathophysiological mechanism in disorders of motivation and addiction.

McCullumsmith RE, Sanacora G. McCullumsmith RE, et al. Among authors: sanacora g. Neuropsychopharmacology. 2015 Jan;40(1):254-5. doi: 10.1038/npp.2014.218. Neuropsychopharmacology. 2015. PMID: 25482181 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters